VERDICTS & SETTLEMENTS
Generic Case Proceeds
CAMDEN, N.J. — A federal judge on October 18 refused to dismiss claims that Actelion Pharmaceuticals Ltd. violated antitrust laws by refusing to share samples of its drugs Tracleer and Zavesca with its generic rivals.
This content has been archived. It is available exclusively through our partner LexisNexis®.
To view this content, please continue to Lexis Advance®.
Not a Lexis Advance® Subscriber? Subscribe Now
For questions call 1-877-256-2472 or contact us at firstname.lastname@example.org